Article
G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression
2020-12-09
Abstract excerpt
<h4>Background: </h4> Clear cell renal cell carcinoma (ccRCC) is a cell metabolic disease with high metastasis rate and poor prognosis. Our previous studies demonstrate that glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the pentose phosphate pathway, is highly expressed in ccRCC and predicts poor outcomes of ccRCC patients. The aims of this study were to confirm the oncogenic role...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 06b103bf-389c-5560-9d8e-32acd58c7200
- DOI
- 10.21203/rs.3.rs-110205/v1
